X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4265) 4265
Book Review (1166) 1166
Publication (501) 501
Book Chapter (33) 33
Conference Proceeding (13) 13
Journal / eJournal (4) 4
Web Resource (3) 3
Dissertation (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3242) 3242
humans (2954) 2954
oncology (1989) 1989
high-grade gliomas (1923) 1923
female (1522) 1522
male (1511) 1511
high-grade glioma (1497) 1497
clinical neurology (1350) 1350
glioblastoma (1324) 1324
middle aged (1262) 1262
adult (1229) 1229
aged (1041) 1041
brain neoplasms - pathology (934) 934
gliomas (922) 922
cancer (835) 835
radiotherapy (821) 821
chemotherapy (769) 769
surgery (740) 740
glioma (727) 727
radiology, nuclear medicine & medical imaging (711) 711
tumors (691) 691
glioblastoma multiforme (676) 676
prognosis (673) 673
survival (662) 662
brain tumors (660) 660
malignant glioma (648) 648
brain-tumors (644) 644
medicine & public health (641) 641
glioblastoma-multiforme (630) 630
brain neoplasms - drug therapy (629) 629
magnetic resonance imaging (604) 604
temozolomide (592) 592
glioma - pathology (568) 568
brain neoplasms - therapy (526) 526
treatment outcome (503) 503
radiation-therapy (481) 481
neurology (466) 466
animals (460) 460
malignant gliomas (460) 460
care and treatment (457) 457
retrospective studies (450) 450
glioblastoma - pathology (447) 447
adolescent (439) 439
neurosciences (417) 417
brain neoplasms - mortality (402) 402
child (396) 396
brain neoplasms - surgery (391) 391
brain (387) 387
phase-ii trial (387) 387
brain neoplasms - diagnosis (382) 382
glioblastoma - drug therapy (378) 378
brain neoplasms - radiotherapy (358) 358
glioma - drug therapy (358) 358
bevacizumab (357) 357
young adult (355) 355
brain cancer (349) 349
combined modality therapy (349) 349
analysis (333) 333
brain neoplasms - genetics (327) 327
research (327) 327
aged, 80 and over (319) 319
newly-diagnosed glioblastoma (315) 315
central-nervous-system (308) 308
adjuvant temozolomide (303) 303
dacarbazine - analogs & derivatives (293) 293
survival analysis (292) 292
brain neoplasms - metabolism (288) 288
glioblastoma - therapy (288) 288
neurosurgery (284) 284
brain neoplasms - diagnostic imaging (283) 283
magnetic resonance imaging - methods (276) 276
radiation (268) 268
glioma - therapy (267) 267
antineoplastic agents - therapeutic use (264) 264
radiation therapy (260) 260
survival rate (260) 260
phase-ii (259) 259
article (258) 258
glioblastoma - mortality (257) 257
therapy (247) 247
diagnosis (241) 241
patients (240) 240
multiforme (239) 239
disease progression (237) 237
child, preschool (236) 236
disease-free survival (234) 234
health aspects (233) 233
mri (230) 230
follow-up studies (228) 228
positron-emission-tomography (228) 228
angiogenesis (223) 223
neuroimaging (223) 223
pediatrics (219) 219
neoplasm grading (218) 218
recurrent glioblastoma (218) 218
development and progression (214) 214
glioblastoma - radiotherapy (208) 208
children (207) 207
in-vivo (205) 205
brain tumor (204) 204
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4175) 4175
French (55) 55
German (22) 22
Spanish (19) 19
Czech (8) 8
Japanese (7) 7
Korean (3) 3
Portuguese (3) 3
Turkish (2) 2
Hungarian (1) 1
Italian (1) 1
Polish (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 81, Issue 4, pp. 1049 - 1058
Purpose L-[methyl-11 C]methionine (MET)–positron emission tomography (PET) has a high sensitivity and specificity for imaging of gliomas and metastatic brain... 
Radiology | Hematology, Oncology and Palliative Medicine | FET-PET | Pseudoprogression | Gross tumor volume | MET-PET | Brain tumors | AMINO-ACID PET | COMPUTED-TOMOGRAPHY | CEREBRAL GLIOMAS | POSITRON-EMISSION-TOMOGRAPHY | ONCOLOGY | IN-VIVO | MALIGNANT GLIOMAS | CT BRAIN | HIGH-GRADE GLIOMAS | GLIAL NEOPLASMS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | METHIONINE | Brain - diagnostic imaging | Prospective Studies | Neoplasm Recurrence, Local - metabolism | Brain Neoplasms - diagnostic imaging | Humans | Brain Neoplasms - pathology | Positron-Emission Tomography - methods | Tumor Burden | Tyrosine - analogs & derivatives | Brain Neoplasms - metabolism | Glioma - metabolism | Brain - metabolism | Neoplasm, Residual | Magnetic Resonance Imaging | Brain Neoplasms - secondary | Glioma - diagnostic imaging | Methionine - analogs & derivatives | Neoplasm Recurrence, Local - diagnostic imaging | Time Factors | Glioma - pathology | Sensitivity and Specificity | Methionine - pharmacokinetics | Tyrosine - pharmacokinetics | Tyrosine | Care and treatment | PET imaging | Gliomas | Radiation | Taxation | Metastasis | Comparative analysis | Index Medicus | GLIOMAS | HALF-LIFE | PATIENTS | CARBON 11 | SPECIFICITY | CYCLOTRONS | METASTASES | SENSITIVITY | HISTOLOGY | NMR IMAGING | TYROSINE | POSITRON COMPUTED TOMOGRAPHY | RADIOLOGY AND NUCLEAR MEDICINE | BRAIN | FLUORINE 18
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 1/2013, Volume 40, Issue 1, pp. 22 - 33
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 05/2017, Volume 58, Issue 5, pp. 700 - 705
Restoration of the blood-brain barrier (BBB) after antiangiogenic therapy of gliomas with bevacizumab may result in a decrease in contrast enhancement on MRI... 
F-FET PET | Evans blue dye | Blood-brain barrier | PET | Glioblastoma | Bevacizumab | blood-brain barrier | RECURRENT GLIOMA | AMINO-ACID PET | VALUABLE DIAGNOSTIC-TOOL | RESPONSE ASSESSMENT | PROGNOSTIC VALUE | UPTAKE KINETICS | F-18-FET PET | glioblastoma | POSITRON-EMISSION-TOMOGRAPHY | NEUROONCOLOGY WORKING GROUP | bevacizumab | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | HIGH-GRADE GLIOMA | Reproducibility of Results | Radiopharmaceuticals - pharmacokinetics | Bevacizumab - administration & dosage | Brain Neoplasms - diagnostic imaging | Capillary Permeability - drug effects | Rats | Male | Positron-Emission Tomography - methods | Blood-Brain Barrier - drug effects | Tyrosine - analogs & derivatives | Brain Neoplasms - metabolism | Glioma - metabolism | Animals | Blood-Brain Barrier - diagnostic imaging | Glioma - diagnostic imaging | Sensitivity and Specificity | Tyrosine - pharmacokinetics | Therapy | Nuclear magnetic resonance--NMR | Brain tumors | Membrane permeability | Fluorescence | Restoration | Neostriatum | Xenografts | Tomography | Tyrosine | Immunodeficiency | Positron emission | Histology | Permeability | Studies | Autoradiography | Magnetic resonance imaging | Antiangiogenics | Influence | Glioblastoma cells | Diagnostic systems | Positron emission tomography | Viability | Tumors | Long-term effects | Index Medicus
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 08/2011, Volume 17, Issue 16, pp. 5473 - 5480
Journal Article
Acta Neuropathologica, ISSN 0001-6322, 12/2016, Volume 132, Issue 6, pp. 917 - 930
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2008, Volume 70, Issue 2, pp. 515 - 522
Purpose To assess the importance of11 C-methionine (MET)–positron emission tomography (PET) for clinical target volume (CTV) delineation. Methods and Materials... 
Radiology | Hematology, Oncology and Palliative Medicine | Malignant gliomas | Methionine–positron emission tomography (PET) | Treatment planning | Image fusion | Carbon ion radiotherapy | Methionine-positron emission tomography (PET) | GA-68 EDTA | image fusion | GLIOBLASTOMA-MULTIFORME | C-11 METHIONINE | carbon ion radiotherapy | COMPUTED-TOMOGRAPHY | CEREBRAL GLIOMAS | RADIATION-THERAPY | treatment planning | methionine-positron emission tomography (PET) | ONCOLOGY | malignant gliomas | HIGH-GRADE GLIOMAS | GLIAL NEOPLASMS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | BRAIN | PET | Astrocytoma - radiotherapy | Radiotherapy Planning, Computer-Assisted - methods | Brain Neoplasms - diagnostic imaging | Humans | Middle Aged | Methionine | Magnetic Resonance Imaging - methods | Tomography, X-Ray Computed - methods | Male | Positron-Emission Tomography - methods | Tumor Burden | Glioblastoma - radiotherapy | Astrocytoma - diagnostic imaging | Brain Neoplasms - surgery | Glioblastoma - surgery | Glioblastoma - diagnostic imaging | Adult | Female | Aged | Retrospective Studies | Brain Neoplasms - radiotherapy | Astrocytoma - surgery | Carbon Radioisotopes | Index Medicus | GLIOMAS | SURGERY | PATIENTS | CARBON 11 | NMR IMAGING | IMAGES | POSITRON COMPUTED TOMOGRAPHY | RADIOLOGY AND NUCLEAR MEDICINE | CARBON IONS | RADIOTHERAPY | METHIONINE | PLANNING
Journal Article
Journal of Magnetic Resonance Imaging, ISSN 1053-1807, 10/2013, Volume 38, Issue 4, pp. 852 - 860
Journal Article
Past, present and future perspectives of genetic therapy in gliomas, 12/2005
High-grade gliomas are relatively frequent in adults and consist in the most malignant form of primary brain tumor. They are resistant to standard treatment... 
Brain tumors, genetic therapy, gene transfer, high-grade gliomas
Journal